Device developed at Washington University may allow sensations in prosthetic hands
To the nearly 2 million people in the United States living with the loss of a limb, prosthetic devices provide restored mobility, yet lack sensory feedback. A team of engineers and researchers at Washington University is working to change that so those with upper limb prosthetics can feel hot and cold and the sense of touch through their prosthetic hands.
New insight into inflammatory bowel disease may lead to better treatments
A newly discovered link between bacteria and immune cells sheds light on inflammatory bowel disease, an autoimmune condition that affects 1.6 million people in the United States, according to researchers at Washington University School of Medicine in St. Louis.
New technology may reduce deadly complication of bone marrow transplants
Researchers led by John F. DiPersio, MD, PhD, at the School of Medicine have designed a way to mitigate graft-versus-host disease, a common and often life-threatening complication of bone marrow transplants that are used to treat leukemia and other blood cancers. The method also employs a molecular imaging tool to help doctors identify patients most likely to develop this dangerous condition.
Trial to study whether statins reduce strokes, heart attacks in HIV patients
The Washington University AIDS Clinical Trials Unit is the first in the nation to open a clinical trial evaluating whether statins reduce heart attacks and strokes in patients with human immunodeficiency virus (HIV).
Scientists find new link between diabetes and Alzheimer’s
Researchers have uncovered a unique connection between
diabetes and Alzheimer’s disease, providing further evidence that a
disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at
Washington University School of Medicine in St. Louis.
Needleman elected to American Academy of Arts and Sciences
Philip Needleman, PhD, former chair of the Department of Pharmacology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Academy of Arts and Sciences.
Innovative family planning clinic recruiting study participants
Washington University School of Medicine and the Brown School have received a $4 million grant to study whether a new model of providing family planning services can reduce unintended pregnancies and births. As part of the study, they are recruiting 10,000 women of child-bearing age in the St. Louis area to participate.
Light — not pain-killing drugs — used to activate brain’s opioid receptors
Washington University School of Medicine neuroscientists, led by Michael R. Bruchas, PhD, assistant professor of anesthesiology and of neurobiology, have attached the light-sensing protein rhodopsin to opioid receptor parts to activate the receptor pathways using light from a laser fiber-optic device. They also influenced the behavior of mice using light, rather than drugs, to activate the reward response.
Discovery may open door for treating fragile X carriers
Fragile X syndrome, an inherited cause of autism and intellectual disability, can have consequences even
for carriers of the disorder who don’t have full-blown symptoms. Researchers at Washington University School of Medicine in St. Louis have identified
a potential target for treatment for fragile X carriers.
Major pathway identified in nerve cell death offers hope for therapies
New research highlights how nerves – whether harmed by disease or traumatic injury – start to die, a discovery that unveils novel targets for developing drugs to slow or halt devastating neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and amyolateral sclerosis as well as peripheral nerve damage.
Older Stories